Related Experiment Video

Updated: Aug 7, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Management of advanced non-small cell lung cancer: current trends

Eric B Haura1

  • 1Thoracic Oncology Program and Clinical Investigations Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA. hauraeb@moffitt.usf.edu

Current Opinion in Pulmonary Medicine
|June 11, 2002
PubMed

Insights

Lung cancer remains a leading cause of death. This review discusses advances in treating advanced non-small cell lung cancer (NSCLC), focusing on combination chemotherapy, biologic agents, and predictive biomarkers.

Area of Science:

  • Oncology
  • Pulmonology

Background:

  • Non-small cell lung cancer (NSCLC) is a significant cause of cancer mortality.
  • Despite advances in chemotherapy and novel agents, 5-year survival for advanced NSCLC remains low at 14%.

Purpose of the Study:

  • To review current trends in the treatment of advanced non-small cell lung cancer.
  • To identify key areas for improving patient outcomes in NSCLC.

Main Methods:

  • Literature review of recent advancements in NSCLC treatment.
  • Discussion of emerging therapeutic strategies and predictive markers.

Main Results:

  • Combination chemotherapy and novel biologic agents represent key advancements.
  • Predicting patient response to chemotherapy is crucial for treatment optimization.

Conclusions:

  • Continued research in combination therapies and targeted biologic agents is essential.
  • Developing predictive biomarkers will enhance personalized treatment approaches for advanced NSCLC.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...